From: Extracellular High-Mobility Group Box 1 Protein (HMGB1) as a Mediator of Persistent Pain
Pain model | Nociceptive assessment | HMGB1 inhibition | Route of drug administration | Species | Reference |
---|---|---|---|---|---|
Nerve injury pain | Â | Â | Â | Â | Â |
SNL | Mechanical (VF); thermal (hotplate) | HMGB1 Ab | Peri-sciatic | Rat | 56 |
Nucleus pulposus | Mechanical (VF) | HMGB1 Ab | Intraperitoneal | Rat | 76 |
TNI | Mechanical (VF) | Glycyrrhizin | Intraperitoneal | Rat | 37 |
Diabetes | Mechanical (VF) | HMGB1 Ab | Intrathecal | Mouse | 80 |
PSNL | Mechanical (VF) | HMGB1 Ab | Intravenous | Rat | 75 |
Inflammatory pain | Â | Â | Â | Â | Â |
LPS paw | Mechanical (VF); thermal (thermal analgesia meter) | HMGB1 Ab | Intraplantar | Rat | 59 |
HMGB1 Ab | Intraplantar | Rat | 59 | ||
Arthritis | Mechanical (VF) | HMGB1 Ab; Abox | Intrathecal | Mouse | 65 |
Other pain | Â | Â | Â | Â | Â |
Bone cancer | Mechanical (VF) | HMGB1 Ab | Intrathecal | Rat | 79 |
Cyclophosphamide-induced bladder pain | Mechanical (VF) | Thrombomodulin; HMGB1 Ab | Intraperitoneal | Mouse | 61 |